Inhibrx Biosciences, Inc. INBX EV / sales
EV / sales at other companies
Other financials
Where this comes from
Calculated from Inhibrx Biosciences, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s ev / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s EV / sales?
- Inhibrx Biosciences, Inc. (INBX) reported EV / sales of 870.6× in Q4 2025.
- How has Inhibrx Biosciences, Inc.'s EV / sales changed year-over-year?
- Inhibrx Biosciences, Inc.'s EV / sales increased by 122.1% year-over-year, from 391.9× to 870.6×.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s EV / sales?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s EV / sales has grown at a 80.3% compound annual growth rate (CAGR), from 267.9× to 870.6×.
- What does EV / sales mean?
- Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.